Sepsis-Associated Encephalopathy
Showing 26 - 50 of >10,000
Prognosis of Neonatal KCNQ2 Gene-associated Epileptic
Recruiting
- Seizures
- +7 more
- KCNQ2
-
Shanghai, Shanghai, ChinaChildren Hospital of Fudan University
Jan 3, 2022
NGAL and Renal Resistive Index in Diagnosis and Prognosis of
Not yet recruiting
- Sepsis
- Acute Kidney Injury
- neutrophil gelatinase-associated lipocalin
- renal resistive index
-
Malatya, TurkeyAyse Belin B OZER
May 10, 2022
Central Venous Catheter Line Associated Infection Risk
Not yet recruiting
- Artificial Intelligence
- Central Venous Catheter Associated Bloodstream Infection
- (no location specified)
Jun 13, 2023
Sepsis Syndrome Trial in New Orleans (MMR vaccine)
Recruiting
- Sepsis Syndrome
- MMR vaccine
-
New Orleans, LouisianaClinical and Translational Research Center
Apr 4, 2022
Chlorhexidine Bathing and Central Line-Associated Infections in
Completed
- Central Line-associated Bloodstream Infection (CLABSI)
- Chlorhexidine bathing
-
Taipei, TaiwanNational Taiwan University Hospital
Jun 25, 2023
Sepsis-Associated Organ Dysfunction, RTT Trial in Guangzhou (continuous renal replacement therapies)
Recruiting
- Sepsis-Associated Organ Dysfunction
- RTT
- continuous renal replacement therapies
-
Guangzhou, Guangdong, China
- +1 more
Dec 21, 2021
Factors Associated With Decisions to Withhold or Withdraw
Completed
- Sepsis
- +2 more
- Treatment in an intensive care unit with a diagnosis of sepsis and/or ARDS and/or covid-19
-
Uppsala, SwedenUppsala University, department of Surgical Sciences
May 23, 2022
Coagulation Disturbances in COVID-19 Septic Patients
Completed
- Coagulation Disorder
- +3 more
- CAC in septic patients
-
Zenica, Bosnia and HerzegovinaCantonal Hospital
Aug 10, 2022
COVID-19-Associated Encephalitis, Multisystem Inflammatory Syndrome in Children Trial in Taipei (delineate its prognostic
Recruiting
- COVID-19-Associated Encephalitis
- Multisystem Inflammatory Syndrome in Children
- delineate its prognostic biomarker, host genetic factors, immunopathogenesis and viral pathogenesis
-
Taipei, Chung Cheng District, TaiwanNational Taiwan University Hospital
Oct 12, 2022
Necrotizing Soft Tissue Infection, Sepsis Trial in Wichita (HAT, Placebo)
Recruiting
- Necrotizing Soft Tissue Infection
- Sepsis
- HAT
- Placebo
-
Wichita, KansasAscension Via Christi Hospital - St. Francis Campus
Dec 13, 2021
Evaluating the NeoTree in Malawi and Zimbabwe
Recruiting
- Prematurity
- +9 more
- Neotree
-
Lilongwe, Malawi
- +4 more
May 17, 2022
Blood Stream Infections, Ventilator Associated Pneumonia, Healthcare Associated Infection Trial (Rapid Diagnostics)
Not yet recruiting
- Blood Stream Infections
- +4 more
- Rapid Diagnostics
- (no location specified)
Jul 31, 2023
CLABSI - Central Line Associated Bloodstream Infection Trial (Arrow Three-Lumen Central Venous Catheter, Arrowg+ard Blue Plus®
Not yet recruiting
- CLABSI - Central Line Associated Bloodstream Infection
- Arrow Three-Lumen Central Venous Catheter
- Arrowg+ard Blue Plus® Three-Lumen Central Venous Catheter
- (no location specified)
Jul 26, 2023
Sepsis, Sepsis-induced Coagulopathy, Nafamostat Mesilate Trial (Nafamostat mesilate, 5% glucose)
Not yet recruiting
- Sepsis
- +2 more
- Nafamostat mesilate
- 5% glucose
- (no location specified)
Oct 5, 2023
Central Line-associated Bloodstream Infection (CLABSI) Trial in Utrecht (TauroLock-Hep100 (taurolidine 1.35%, citrate 4%,
Recruiting
- Central Line-associated Bloodstream Infection (CLABSI)
- TauroLock-Hep100 (taurolidine 1.35%, citrate 4%, heparin 100 IU/mL)
- Heparin lock (heparin 100 IU/mL)
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 13, 2023
Disseminated Intravascular Coagulation Trial (Antithrombin alfa (INN name), Control (Standard treatment))
Terminated
- Disseminated Intravascular Coagulation
- Antithrombin alfa (INN name)
- Control (Standard treatment)
- (no location specified)
Aug 5, 2021
CARPEDIEM® inFrench National Cohort of 25 Neonates and Small
Completed
- Hypoxic-Ischemic Encephalopathy
- +6 more
- CARPEDIEN
-
Nice, FranceCHU de Nice
Aug 8, 2022
Hemodialysis Catheter-Associated Bacteremia, Hemodialysis Complication Trial in Roskilde (Ethanol 70%, Isotonic saline with
Active, not recruiting
- Hemodialysis Catheter-Associated Bacteremia
- Hemodialysis Complication
- Ethanol 70%
- Isotonic saline with heparin
-
Roskilde, DenmarkZealand University Hospital
Jul 12, 2023
Central-line Associated Blood Stream Infections (CLABSI) Trial (2-octyl cyanoacrylate based topical skin adhesive)
Not yet recruiting
- Central-line Associated Blood Stream Infections (CLABSI)
- 2-octyl cyanoacrylate based topical skin adhesive
- (no location specified)
Feb 9, 2023
Oncology, Critical Illness, Sepsis Trial in Iasi (indwelling device biofilm identification)
Active, not recruiting
- Oncology
- +3 more
- indwelling device biofilm identification
-
Iasi, RomaniaRegional Institute of Oncology
Mar 14, 2022
Using Microbial Genomics to Elucidate Source of Central-line
Recruiting
- Laboratory-confirmed Bloodstream Infection
- +2 more
-
Boston, MassachusettsBoston Children's Hospital
Mar 7, 2022
Acute Respiratory Failure, Encephalopathy, ARDS Trial in San Diego, Baltimore, Burlington (Exersides)
Completed
- Acute Respiratory Failure
- +4 more
- Exersides
-
San Diego, California
- +2 more
Mar 8, 2022
CLABSI - Central Line Associated Bloodstream Infection Trial in Baltimore (Sodium Citrate 4% Inj Syringe 3Ml)
Recruiting
- CLABSI - Central Line Associated Bloodstream Infection
- Sodium Citrate 4% Inj Syringe 3Ml
-
Baltimore, MarylandJohns Hopkins
Oct 12, 2022
Central Line-associated Bloodstream Infection (CLABSI) Trial in Aarhus, Odense (Hydrochloric Acid (2 M), Normal saline)
Recruiting
- Central Line-associated Bloodstream Infection (CLABSI)
- Hydrochloric Acid (2 M)
- Normal saline
-
Aarhus, Denmark
- +1 more
Jun 21, 2022